Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Ho Ji

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
The Lancet. Oncology|December 7, 2020
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trialJonathan W Goldman, Mikhail Dvorkin, Yuanbin Chen, et al.
The Oncologist|July 9, 2017
Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III TrialSe-Il Go, Dong-Hoe Koo, Seung Tae Kim, et al.
Cancer Communications (London, England)|October 18, 2019
Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Cancer Research and Treatment|September 2, 2015
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and HistologyJun Ho Yi, Jung Hun Kang, In Gyu Hwang, et al.
The Oncologist|September 8, 2019
A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin ToxicitiesYoung Saing Kim, Jun Ho Ji, Sung Yong Oh, et al.
Cancer Discovery|July 19, 2019
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella TrialJeeyun Lee, Seung Tae Kim, Kyung Kim, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
The Lancet. Oncology|December 7, 2020
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trialJonathan W Goldman, Mikhail Dvorkin, Yuanbin Chen, et al.
The Oncologist|July 9, 2017
Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III TrialSe-Il Go, Dong-Hoe Koo, Seung Tae Kim, et al.
Cancer Communications (London, England)|October 18, 2019
Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Cancer Research and Treatment|September 2, 2015
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and HistologyJun Ho Yi, Jung Hun Kang, In Gyu Hwang, et al.
The Oncologist|September 8, 2019
A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin ToxicitiesYoung Saing Kim, Jun Ho Ji, Sung Yong Oh, et al.
Cancer Discovery|July 19, 2019
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella TrialJeeyun Lee, Seung Tae Kim, Kyung Kim, et al.
Pageof 7